Univest
Univest
  • Markets

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Falls for Third Session

  • September 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
MANIPALHOS Share Price
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) share price fell to Rs 653.65 today, down 2.14% from the previous close. Market cap was Rs 89,254.92 crore.

MANIPALHOS Share Price was at Rs 653.65, down 2.14% from the previous close, with market capitalisation at Rs 89,254.92 crore. According to latest Univest figures, the stock is in its third consecutive session of decline, and the cumulative move from the streak start base price of Rs 701.1 is -6.77%. MANIPALHOS Share Price matters today because the move combines a fresh intraday fall with a higher-than-median valuation profile in Healthcare, while the latest Univest data also place it among large-cap healthcare names. In this MANIPALHOS Share Price update, the day’s decline, the company’s fundamentals and the healthcare benchmark all give context for why the stock is drawing attention in Manipal Health Enterpri L Share Price Today, Manipal Health Enterpri L Stock News and Manipal Health Enterpri L Share Price News discussions.

The price move is confirmed in Univest data; a company-specific reason has not been established.

Table of Contents

Toggle
  • MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Today: Price Action Analysis
  • MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching MANIPALHOS
  • About Manipal Health Enterpri L
  • Track MANIPALHOS Share Price on Univest
  • Frequently Asked Questions
    • What is the current MANIPALHOS Share Price?
    • What is the market capitalisation of MANIPALHOS?
    • How does MANIPALHOS compare with healthcare peers?
    • What does the P/E ratio say about MANIPALHOS Share Price?
    • What do ROE and ROCE show for MANIPALHOS?
    • What is the EPS and book value for MANIPALHOS?
    • Does MANIPALHOS pay a dividend?
    • What should investors monitor next in MANIPALHOS Share Price?

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 653.65
Previous Close Rs 667.95
Today's Move -Rs 14.30 (-2.14%)
Open Rs 668.25
High Rs 668.35
Low Rs 653.45
Market Capitalisation Rs 89,254.92 crore
Market Cap Category Large Cap

MANIPALHOS Share Price opened at Rs 668.25, touched a high of Rs 668.35 and a low of Rs 653.45, and last traded at Rs 653.65. The previous close was Rs 667.95, so the stock moved Rs 14.30 lower during the session. The range shows that MANIPALHOS Share Price stayed close to the lower end of the day’s trading band, which is useful context for today’s share price fall. The company’s market capitalisation of Rs 89,254.92 crore places it in the Large Cap category, and that size context matters when reading Manipal Health Enterpri L Share Price Today. Since this is the third consecutive session of decline, MANIPALHOS Share Price should be read as a streak move rather than an isolated single-day slip. From here, the more important question becomes how the valuation and company metrics compare with the Healthcare set that investors track in Manipal Health Enterpri L Stock News.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 89,254.92 crore
P/E Ratio 98.46x
P/B Ratio 5.29x
ROE 12.95%
ROCE 13.93%
EPS Rs 6.78
Book Value Per Share Rs 126.18
Dividend Yield 0%

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) fundamental metrics show P/E 98.46x, P/B 5.29x, ROE 12.95%, ROCE 13.93%. These ratios show where the company stands today and are not a call to buy or sell.

MANIPAL HEALTH ENTERPRI L has a market capitalisation of Rs 89,254.92 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 98.46x, P/B at 5.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.95% and ROCE of 13.93%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.78, book value per share of Rs 126.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.84x, median ROE of 12.95%, median ROCE of 15.83%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 98.46x
Benchmark Median P/E 42.84x
Benchmark Average P/E 92.97x
Benchmark P/E Range 6.82x to 1,502.88x
Company P/B Ratio 5.29x
Benchmark Median P/B 3.75x
Benchmark Average P/B 4.03x
Company ROE 12.95%
Benchmark Median ROE 12.95%
Benchmark Average ROE 11.24%
Company ROCE 13.93%
Benchmark Median ROCE 15.83%
Benchmark Average ROCE 2.2%
Company Market Capitalisation Rs 89,254.92 crore
Benchmark Median Market Cap Rs 507.36 crore
Benchmark Average Market Cap Rs 10,212.49 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 98.46x, which is above the benchmark median of 42.84x, a difference of +129.83%. A P/E difference of this kind is a reference point rather than a recommendation.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of 12.95%, which is equal to the benchmark median of 12.95%, a difference of 0%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of 13.93%, which is below the benchmark median of 15.83%, a difference of -12%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise APOLLOHOSP 1,12,225.36 54.18 11.69 23.54 21.73
Max Healthcare Institute MAXHEALTH 84,580.66 57.68 7.69 14.53 14.97
Aster DM Healthcare ASTERDM 59,426.27 188.46 14.2 13.07 16.22
Fortis Healthcare FORTIS 57,188.08 54.47 5.62 11.32 14.07
Global Health MEDANTA 35,176.89 61.94 8.38 15.12 19.38

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 98.46x compared with the displayed peer median of 57.68x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.95% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 13.93% versus the displayed peer median of 16.22%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 89,254.92 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching MANIPALHOS

  • MANIPALHOS Share Price fell 2.14% today and is in its third consecutive session of decline.
  • The stock’s Large Cap market capitalisation of Rs 89,254.92 crore keeps it prominent within Healthcare.
  • MANIPALHOS Share Price carries a P/E of 98.46, above the industry median of 42.84.
  • ROE of 12.95% is at the industry median, while ROCE of 13.93% is below the median of 15.83%.
  • Peer comparison shows MANIPALHOS Share Price trading at a richer P/E than Apollo Hospitals, Max Healthcare and Fortis.

About Manipal Health Enterpri L

Manipal Health Enterpri L operates in Healthcare, within the Hospital & Healthcare Services industry. The company is part of a large hospital platform in India and is tracked by investors alongside other listed healthcare providers. Its market position is best understood through scale, profitability ratios and valuation, rather than through a single day’s share price move. MANIPALHOS Share Price therefore reflects both the business profile and the broader industry setting in which hospitals are evaluated on return ratios, pricing power and market capitalisation. The company is part of the Healthcare universe that Univest tracks closely for fundamental analysis and peer comparison.

Track MANIPALHOS Share Price on Univest

Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track MANIPALHOS Share Price on Univest for live updates, fundamental ratios, 52-week levels, market capitalisation, peer context and healthcare industry comparison. Univest also helps you review Manipal Health Enterpri L Stock News, Manipal Health Enterpri L Share Price Today and Manipal Health Enterpri L Fundamental Analysis in one place. That makes it easier to follow price action and valuation together.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the current MANIPALHOS Share Price?

Ans. MANIPALHOS Share Price last traded at Rs 653.65. The stock was down Rs 14.30 from the previous close of Rs 667.95, with the day’s range spanning Rs 653.45 to Rs 668.35.

What is the market capitalisation of MANIPALHOS?

Ans. MANIPALHOS has a market capitalisation of Rs 89,254.92 crore. The company is categorised as a Large Cap name, which places it among the larger listed healthcare companies tracked by Univest.

How does MANIPALHOS compare with healthcare peers?

Ans. MANIPALHOS Share Price carries a higher P/E than Apollo Hospitals, Max Healthcare and Fortis in the peer set provided. Its P/B is lower than Apollo and Max Healthcare, while ROE and ROCE sit in the middle range.

What does the P/E ratio say about MANIPALHOS Share Price?

Ans. MANIPALHOS trades at a P/E of 98.46, above the Healthcare benchmark median of 42.84 and above the benchmark average of 92.97. That places the stock in a premium valuation band versus the industry median.

What do ROE and ROCE show for MANIPALHOS?

Ans. MANIPALHOS has ROE of 12.95% and ROCE of 13.93%. ROE matches the industry median of 12.95%, while ROCE is below the benchmark median of 15.83%, giving useful context for MANIPALHOS Share Price.

What is the EPS and book value for MANIPALHOS?

Ans. EPS is Rs 6.78 and book value is Rs 126.18 per share. These are important fundamental markers for MANIPALHOS Share Price because they show earnings per share and accounting net worth per share.

Does MANIPALHOS pay a dividend?

Ans. The dividend yield shown is 0, so there is no dividend yield contribution in the current snapshot. For MANIPALHOS Share Price, valuation and return ratios therefore carry more weight than income yield.

What should investors monitor next in MANIPALHOS Share Price?

Ans. Investors can monitor whether MANIPALHOS Share Price stabilises after the third consecutive session of decline, and how the stock continues to trade relative to its peer P/E, ROE and ROCE profile.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply